Weekly Cisplatin, Epirubicin, and Paclitaxel With Granulocyte Colony-Stimulating Factor Support vs Triweekly Epirubicin and Paclitaxel in Locally Advanced Breast Cancer: Final Analysis of a SICOG Phase III Study

S. Glück

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Number of pages1
JournalBreast Diseases
Issue number3
StatePublished - Oct 1 2007

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this